
Article 1 
The watch list of substances for Union-wide monitoring referred to in Article 8b of Directive 2008/105/EC is set out in the Annex to this Decision.
Article 2 
Implementing Decision (EU) 2018/840 is repealed.
Article 3 
This Decision is addressed to the Member States.
Done at Brussels, 4 August 2020.
For the Commission
Virginijus SINKEVIČIUS
Member of the Commission
ANNEX

Name of substance/group of substances CAS number EU number Indicative analytical method Maximum acceptable method detection limit (ng/l)
Metaflumizone 139968-49-3 604-167-6 LLE-LC-MS-MS or SPE–LC-MS-MS 65
Amoxicillin 26787-78-0 248-003-8 SPE-LC-MS-MS 78
Ciprofloxacin 85721-33-1 617-751-0 SPE-LC-MS-MS 89
Sulfamethoxazole 723-46-6 211-963-3 SPE-LC-MS-MS 100
Trimethoprim 738-70-5 212-006-2 SPE-LC-MS-MS 100
Venlafaxine andO-desmethylvenlafaxine 93413-69-593413-62-8 618-944-2700-516-2 SPE-LC-MS-MS 6
Azole compounds   SPE-LC-MS-MS 
ClotrimazoleFluconazoleImazalilIpconazoleMetconazoleMiconazolePenconazoleProchlorazTebuconazoleTetraconazole 23593-75-186386-73-435554-44-0125225-28-7125116-23-622916-47-866246-88-667747-09-5107534-96-3112281-77-3 245-764-8627-806-0252-615-0603-038-1603-031-3245-324-5266-275-6266-994-5403-640-2407-760-6  2025080044292001 7001612401 900
Dimoxystrobin 149961-52-4 604-712-8 SPE-LC-MS-MS 32
Famoxadone 131807-57-3 603-520-1 SPE-LC-MS-MS 8,5






